placebo, isotonic ciclesonide, hypotonic ciclesonide
ApprovedWithdrawn 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Allergic Rhinitis
Conditions
Allergic Rhinitis
Trial Timeline
Feb 1, 2009 → —
NCT ID
NCT00793858About placebo, isotonic ciclesonide, hypotonic ciclesonide
placebo, isotonic ciclesonide, hypotonic ciclesonide is a approved stage product being developed by Sumitomo Pharma for Allergic Rhinitis. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT00793858. Target conditions include Allergic Rhinitis.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00793858 | Approved | Withdrawn |
Competing Products
20 competing products in Allergic Rhinitis